CM
IBB icon

Caption Management’s iShares Biotechnology ETF IBB Stock Holding History

Caption Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-125,000
Closed -$21.1M – 1767
2025
Q4 		$21.1M Buy
+125,000
New +$20.3M 0.14% 160
2021
Q1 		– Sell
-75,000
Closed -$11.4M – 1216
2020
Q4 		$11.4M Buy
+75,000
New +$10.7M 0.26% 100
2020
Q1 		– Sell
-80,000
Closed -$9.64M – 955
2019
Q4 		$9.64M Buy
+80,000
New +$8.93M 0.32% 65
2018
Q2 		– Sell
-50,000
Closed -$5.34M – 410
2018
Q1 		$5.34M Buy
+50,000
New +$5.54M 0.76% 37

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Caption Management's IBB Position: Q1 2026 in Review

Caption Management sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 74,000 shares — an estimated $12.5M sold.

Caption Management first reported a position in IBB in Q4 2023 and held it in 6 quarters. The position peaked at $12.5M in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Caption Management reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 74,000 iShares Biotechnology ETF shares in Q1 2026, an estimated $12.5M.
  • Caption Management first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 6 quarters.
  • Caption Management's iShares Biotechnology ETF position peaked at $12.5M in Q4 2025.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.